Healthcare Startup Meeting

How to apply

As a first step, we require all applicants to submit an expression of interest. The BaseLaunch Team evaluates all application inquiries for potential overall fit. If your project meets our requirements, you will, within five business days, receive an invitation to complete your application. The deadline to complete your application is June 30, 2017. The Selection Committee reviews the full proposals and chooses up to 10 promising projects to participate in phase I. At the end of phase I, all projects will be presented to the Selection Committee, which picks up to three startups that can continue to phase II.

Key Dates

 

  • Expression of interest: June 15, 2017
  • Application deadline: June 30, 2017
  • Notification of phase I participants: August 15, 2017
  • Start of phase I: September 15, 2017
  • Notification of phase II participants: November 30, 2017
  • Start of phase II: January 2, 2018

Prerequisites

 

BaseLaunch is looking for individuals or teams with breakthrough healthcare innovations with a major focus on therapeutics. However, should you have a game-changing innovation in diagnostics, medtech or related fields, we would certainly like to receive your application. We welcome projects at the pre-seed to seed funding stage, projects that are on the verge of incorporation or those with clear plans to secure an IP position and/or develop a prototype. BaseLaunch accepts project proposals from around the world — provided there is willingness to establish operations in Basel during the second phase of program.

 

Also, should you be a professor or a group leader with a promising discovery or a valuable IP but lack a team to develop it further, or if you believe your project is not yet mature enough to apply, please also get in touch with us. Should you have already received series A type of funding or similar, you are also welcome to apply if you believe you can benefit from working with us.

Expression of interest

No more expressions of interest are accepted for 2017. Applications will open again in early 2018. If you have questions regarding the application process, please do not hesitate to contact us.

FAQ

How much funding does BaseLaunch have at its disposal to support startups?

During phase I, financial support through BaseLaunch for consultant services can be as high as 10,000 Swiss francs per project to further solidify strategy, R&D plans and operations.

 

For companies in phase II, grants of up to 250,000 Swiss francs per startup may be offered. Funding is expected to be used to reach critical milestones. The amount of funding may vary according to project requirements. In order to be eligible, startups should be incorporated and/or legally registered in the Basel region. Furthermore, BaseLaunch will actively work with the start-ups to raise additional non-dilutive funding from foundations, government grants, etc. and will also facilitate contacts to business angels, venture funds and family offices.

Who can apply for BaseLaunch?

BaseLaunch is looking for individuals or teams with breakthrough healthcare innovations with a major focus on therapeutics. However, should you have a game-changing innovation in diagnostics, medtech or related fields, we would certainly like to receive your application. We welcome projects at the pre-seed to seed funding stage, projects on the verge of incorporation or those with clear plans to secure an IP position and/or develop a prototype. BaseLaunch accepts project proposals from around the world — provided there is willingness to establish operations in Basel during the program.

 

Also, should you be a professor or a group leader with a promising discovery or a valuable IP but lack a team to develop it further, or if you believe your project is not yet mature enough to apply, please get in touch with us. Should you have already received series A type of funding or similar, you also welcome to apply if you believe you can benefit from working with us.

What are the key criteria for a successful application to BaseLaunch?

Solid scientific concepts, an initial development plan, a realistic business case and a strong commitment from the project team.

Do I already need to have incorporated a company?

No, a company does not need to be incorporated nor does it need to be legally registered in Basel in order to be eligible to apply and participate in the program. However, in order to be eligible to receive the grant funding and participate in phase II, startups should be incorporated or in process of incorporation and/or legally registered in the Basel region.

Do the participants need to be physically present in Basel?

In phase I, project teams are encouraged to be physically present in Basel, whereas a physical presence, at least partially, is required during phase II.

Do I need to stay in the region when the program ends?

We believe there is no place better in Europe than the Basel region to start and grow a healthcare company. Once the period of support from BaseLaunch has ended, startups may continue to operate from the Switzerland Innovation Park by assuming the costs of the lab and office space, equipment and consumables or relocate the company somewhere else. However, there are no formal requirements on staying in the region once the program ends.

Confidentiality

Please refer to our Conditions of Application and Privacy Policy.

What are the obligations of startup companies in return for support from BaseLaunch?

Unlike traditional incubators, BaseLaunch offers a more comprehensive and structured approach. We require teams to participate in activities such as working sessions and presentations related to the BaseLaunch program or to BaseLaunch partners. Teams are expected to be physically present, at least partially, during phase II to execute the development plan and have at least some operations of their company in Basel. We do however not require the startups to use the provided infrastructure should they not need it (for instance when there is the possibility to still stay in the university laboratory).

Which milestones must be met during the course of the project?

During phase I, participants are expected to formulate and refine their business case such that they can present it to the Selection Committee. For phase II, milestones are individually defined.

Who owns the intellectual property in projects supported by BaseLaunch and what other commitments apply?

Startups retain all intellectual property rights and hold the freedom to choose their partners. All our healthcare partners require is to be informed eight weeks before the closing of a financing round with an outside investor. All applicants agree to allow BaseLaunch to use the following aspects of their application for marketing purposes: project name, focus area and project description. Further data may be published as described in the Conditions of Participation, section 4 “Confidentiality”.

Which country’s legal framework governs the contracts made?

Contracts concluded with BaseLaunch are governed by the substantive laws and regulations of Switzerland (see Conditions of Participation, section 7 “Miscellaneous”).

Biotech Office Buildings